Abstract
Gastroesophageal reflux disease (GERD) is the most common gastrointestinal complaint seen across the world. It has often been perceived as Western disease due to its high prevalence of around 10–20%. In Asia, limited data showed that the prevalence was 2.5–6.7% and that most patients had mild disease. However, within the last decade, research in GERD showed that the prevalence of weekly heartburn ranges from 8 to 20%, which is higher than previous estimates; however, erosive esophagitis was seen in less than 20% of patients. This increase in prevalence could be due to the changing dynamics mainly due to interaction of environmental, genetic, and recent socioeconomical development in Asia. The diversity in ethnic populations in Asia leads to problem in evaluation of the prevalence of gastroesophageal disease mainly due to the cultural, social, and language differences. The aim of this chapter is to review the epidemiological studies of gastroesophageal disease, including those of erosive esophagitis and Barrett’s esophagus in Asia, and provide an understanding of the regional variation and the changes seen over the last decade.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
Introduction
Gastroesophageal reflux disease (GERD) is one of the most commonly encountered gastrointestinal disease in the world. GERD is a spectrum of disease which includes symptoms like heartburn or regurgitation to complications like erosive esophagitis, Barrett’s esophagus, and related neoplasia. GERD is a condition which develops when the reflux of the stomach contents causes troublesome symptoms and/or complication, as per Montreal definition of GERD [1]. GERD affects 10–20% of the adult population in the USA and Europe [1]. These figures are likely an underestimate of its true prevalence, since many patients self-medicate and/or do not seek medical advice. GERD is often perceived as a Western disease due to limited literature among the Asian population. The reported population prevalence of GERD in Eastern Asia ranges from 2.5 to 6.7% [2].
In the last decade, the Asia-Pacific region has carried out active research in GERD. Increasing incidence of GERD has been noted among various Asian countries in the last 10 years. The aim of this chapter, therefore, is to review the epidemiologic studies of GERD in Asia, including those of erosive esophagitis, and to provide a realistic understanding of the change of prevalence of GERD over time.
History of GERD in Asia
The regions of Asia include: Eastern (China, Japan, Korea, and Taiwan), Southeastern (Malaysia, Singapore, and Thailand), South Central (India, Iran, Pakistan, and Bangladesh) and Western (Israel and Turkey). The first report in the published English medical literature on GERD was by Kang and colleagues in 1993 [2]. Prior to that, in the late 1970s, two reports from Taiwan mentioned the presence of esophagitis among patients who had undergone gastroscopy [3, 4]. In 2005, Dent and colleagues estimated that the prevalence of GERD was 10–20% in Western countries and approximately 5% in Asia, in a systematic review of studies that defined GERD as symptoms of heartburn and/or regurgitation occurring on at least 1 day per week [1]. Similarly, in another systematic review, the prevalence of GERD in Asia was estimated to range between 2.5 and 6.7% [5]. However, recently many studies from Asia have shown an increasing trend in the prevalence of GERD. There are substantial differences in GERD prevalence among Asian regions. The prevalence is highest in West Asia (12.5–27.6%), less so in Central Asia (7.6–19.4%), and lowest in East Asia (2.5–9.4%) [7].
Measuring the Burden of GERD
The exact burden of GERD is difficult to measure, as endoscopy only measures erosive esophagitis. The true prevalence of GERD in the community with questionnaire or direct questioning will also provide vital information in estimating the prevalence, as a large number of people who suffer from GERD do not visit a physician for this complaint. There are also some language and cultural differences in symptom interpretation such as the lack of the exact word for heartburn in some Asian languages, making it difficult to accurately estimate the prevalence of GERD in these populations. For example, in Korean, Malay, and Chinese, there is no direct word describing the symptom, and a survey in the USA revealed that only 13.2% of East Asian patients understood the term [6]. There are only a few population-based studies from Asia that have used the Montreal definition or definitions that are close to it.
Prevalence of GERD: Symptom-Based Studies
Eastern Asia (China, Japan, Korea, and Taiwan)
In Eastern Asia, various large-scale population studies have been conducted. The prevalence of GERD was estimated between 6.6 and 20.7% among various populations. In a cross-sectional study by Fukujima et al., the prevalence of GERD was estimated at 6.6% among patients who visited physicians for a routine physical exam. In another survey of 1076 patients who presented with epigastric symptoms between April and August 2007 at 55 institutions in Japan, the prevalence of GERD was estimated at 15.6%, and in another study of 160,973 adults who presented for screening of gastric carcinoma and reported abdominal pain, the prevalence of GERD was between 15.8 and 20.7% [7,8,9].
The prevalence of GERD in China is estimated to be between 1.7 and 7.3%. The largest population-based study among 16,091 subjects by He et al., based on self-reported questionnaire, estimated the prevalence of GERD as 3.1%, varying between 1.7 and 5.1% in different regions [10]. Li et al., in a survey of more than 15, 000 outpatients attending hospitals in Zhejiang province, China, recorded a prevalence of 7.3% [11]. The prevalence of GERD in Shanghai (Weng et al.) and South China (Chen et al.) based on population-based studies was approximately 6.2% [12,13,14]. The prevalence was even lower in Hong Kong, where the prevalence rates of GERD, as estimated by telephonic interviews, were between 0.25 and 4.8% [15, 16].
The prevalence of GERD in South Korea was estimated to be similar to the Western countries at 7.1%, based on telephone interviews among the general population. Based on another population-based study [17] and telephone survey [18] in Korea, its prevalence was estimated at 3.5 and 8.5%, respectively. In Taiwan, using a modified GERD questionnaire, Lu et al. recorded prevalence of 6.6% as once-weekly symptoms [19]. A recent review of changing GERD trends showed that prevalence of symptom-based GERD in Eastern Asia was 5.2–8.5% [4,5,6,7,8,9, 20, 21] from 2005 to 2010, whereas it was 2.5–4.8% [11, 13, 14] before 2005. However, it has stricter criteria for GERD definition for inclusion of the studies.
Southeastern Asia (Malaysia, Singapore, and Thailand)
In Singapore, Ho et al. showed the highest prevalence among Indians (7.5%) and Malays (3%) [22]. In another study that surveyed the same cohort in 1994 and in 1999, the prevalence of GERD was 5.5% ± 1.5% initially, but increased to 10.5% ± 2.0% after 5 years [23]. In Malaysia, Rajendra and Alahuddin in 2004 showed symptomatic prevalence of 9.7% based on patients having monthly symptoms [24]. In Thailand, a study by the Thai motility club (using questionnaire) reported a 7.4% prevalence of GERD in community (unpublished data) (esophagitis 4–6%) [26].
South Central Asia (India, Iran, Pakistan, and Bangladesh)
Most studies in South Central Asia were conducted in Iran. The prevalence of GERD in Iran was 6.3–18.3% from 2005 to 2010, and higher than in Eastern Asia [25,26,27]. The prevalence of GERD in Bangladesh ranged from 5.3 to 19.4% [28, 29]. Jafri et al. reported a prevalence of 24% in Pakistan in 2005 [30]. The prevalence of GERD in India was estimated at 7.6% in a large prospective multicenter study involving 12 centers and 3224 subjects in 2011 [31]. The prevalence of GERD in other questionnaire-based cross-sectional studies ranged between 10.6 and 18.7% [32,33,34].
West Asia (Israel and Turkey)
The prevalence of GERD in West Asia was found to be the highest in all of Asia. The prevalence was found to be 20–27.6% in Turkey [35,36,37]. However, the symptom profile of the Turkish people was said to differ considerably; they have a relatively lower occurrence of heartburn and a higher incidence of regurgitation and dyspepsia. In Israel, Moshkowitz et al. reported prevalence of 12.5% of GERD symptoms [38]. Another population-based study in 2007 also reported a high prevalence of GERD symptoms, including retrosternal burning in 6.5%, retrosternal pain in 5.2%, acid taste in the mouth in 10.4%, and reflux of gastric contents in 7.9% of subjects [39]. Prevalence of GERD in population-based studies is higher in Central and West Asia than in East Asia [38].
Selected studies highlighting the prevalence of reflux symptoms in Asia after year 2000
Study, year [reference] | Country | Method | Sample size | Prevalence of reflux symptoms (%) |
---|---|---|---|---|
Daily/at least weekly/at least monthly/at least yearly | ||||
Eastern Asia | ||||
Stanghellini 1999 [21] | Japan (part of international study | Digest | 500 | Prevalence of 9.8% for heartburn and of 3.6% for regurgitation |
Random house-to-house recruitment | ||||
Fujiwara et al. 2005 [7] | Kansai, Japan | Questionnaire | 6035 (clinic based) | Prevalence of 12.8% (> 2 per month) |
He et al. 2010 [10] | China | Self-reported questionnaires | 16,091 | At least weekly, 5.2%; at least twice a week, 3.1% (2.4% in urban and 3.8% in rural area) |
Pan et al. 2000 [40] | China | Assisted self-completed questionnaire (GERQ) | 4992 | HB 2.5/HB 3.1/HB 7.0 |
Hu et al. 2002 | China | Telephone interview (bowel symptom questionnaire) | 2640 | 4.8 |
Wong et al. 2003 [16] | China | Telephone interview (GERQ) | 3605 | 2.5/8.9/29.8 |
Cho et al. 2005 [17] | Korea | Face-to-face interview (GERQ) | 1902 | GERD 3.5/HB 4.7/AR 4.4 |
2.0/AR 2.0 | ||||
Fujiwara et al. 2005 [7] | Japan | Face-to-face interview | 6035 | 2.1/6.6/19.4/44.1 |
Western & Southern Asia | ||||
Bor et al. 2005 [35] | Turkey | Face-to-face interview (GERQ) | 630 | 4.9/GERD 20/HB GERD 37.6/HB 10/AR 15.6, 15.9/AR 32.7 9, AR 32.7 |
Nouraie et al. 2007 | Iran | Face-to-face interview | 2561 | GERD 21.2/HB 12.2/AR 16.8 |
Pourshams et al. 2007 | Iran | Face-to-face interview | 1000 | 12.3 |
Sperber et al. 2007 [39] | Israel | Telephone interview (RDQ) | 1221 | 0.3/9.3 |
Bhatia et al. 2011 [85] | India | Questionnaire | 3224 | Heartburn 2.7/3.2/12.7 |
Regurgitation 2.0/2.3/9.2 |
Prevalence of Esophagitis
Most endoscopy-based studies were conducted on subjects with upper gastrointestinal symptoms in tertiary care hospitals.
Eastern Asia (China, Japan, Korea, and Taiwan)
Using the Los Angeles classification, the prevalence was estimated between 6.6 and 15.0% [41,42,43,44,45] from nine studies between 2000 and 2005 and 4.3–15.7% [46,47,48,49] after 2005. Several studies were conducted in retrospective manner and may have under- or overestimated the exact prevalence of endoscopic reflux esophagitis. SILC study, [50] a population-based endoscopy study conducted in China, showed symptomatic GERD to be more prevalent among patients who agreed to endoscopy (4.7% vs. 1.7%). Among patients who underwent endoscopy, the prevalence of erosive esophagitis was 6.4% (Los Angeles grade A 4.1%, grade B 2.1%, grade C 0.2%, and grade D 0%, respectively). Erosive esophagitis was also more prevalent among patients with symptomatic GERD (12.5% vs. 6.1%).
Southeastern Asia (Malaysia, Singapore, and Thailand)
In Malaysia, the prevalence of erosive esophagitis was estimated at 13.4% among 1000 patients with upper abdominal discomfort [51]. Similarly, Rajendra et al. showed prevalence of erosive esophagitis as 6.1% in 1985 patients with abdominal discomfort or reflux [52]. In Singapore, several studies showed prevalence of reflux esophagitis between 5 and 6.9% [53, 52].
Western Asia (Israel and Turkey)
In Saudi Arabia, Al-Humayed et al. reported a prevalence of 15% in 1607 patients who underwent endoscopy for evaluation of dyspepsia [54]. A retrospective analysis of 18,766 endoscopies by Yilmaz et al. in Turkey between 1996 and 2001 reported prevalence of erosive esophagitis as 12.8% [54].
Prevalence of Extra-Esophageal Syndromes
Extra-esophageal syndromes include respiratory symptoms, such as chronic cough, asthma, or laryngitis, dental erosions, noncardiac chest pain (NCCP), and sleep disturbance [55]. In a study by Shimizu et al. [56], the proportion of endoscopic reflux esophagitis in patients with asthma was higher than in controls (39.3% vs. 0.6%). The proportion of sleep dysfunction was 52.5–56.6% among the patients with GERD [57,58,59]. In tertiary hospitals in China, dental erosions were found in 64.5% among patients with frequent reflux symptoms (three to five times per week), 44.4% among subjects with occasional symptoms (one to two times per week), and 36.7% among controls (p < 0.05) [60]. The prevalence of GERD among patients with NCCP was 66.7% and 20%, respectively, in Malaysia [61] and Turkey [35].
Selected Studies Highlighting the Prevalence of Erosive Esophagitis in Asia
Study, year [reference] | Country | Target population | Sample size | Prevalence of esophagitis (%) |
---|---|---|---|---|
Southern Asia | ||||
Khuroo et al., 1989 | India | Patients with dyspepsia | 239 | 5.60 |
Nasseri-Moghaddam et al., 2003 | Iran | Patients with dyspepsia referred for upper endoscopy | 269 | 76.90 |
Southeastern Asia | ||||
Kang et al., 1993 [2] | Singapore | Patients with upper GI symptoms (inpatients and outpatients) | 11,943 | 4.50 |
Rosaida et al., 2004 [51] | Malaysia | Patients with upper abdominal discomfort | 1000 | 13.40 |
Eastern Asia | ||||
Yeh et al., 1997 [62] | Taiwan | Patients with upper GI symptoms (heartburn, regurgitation, epigastric pain, and GI bleeding) | 464 | 14.50 |
Yeom et al., 1999 | Korea | Patients with GI tract symptoms | 1010 | 5.30 |
Furukawa et al., 1999 [63] | Japan | Patients requiring routine physical examinations | 6010 | 16.30 |
Inamori et al., 2003 [64] | Japan | First time endoscopy in patients with heartburn, dyspepsia, noncardiac chest pain | 392 | 13.80 |
Western Asia | Turkey | Patients with dyspepsia referred for upper endoscopy | 395 | 15.40 |
Toruner et al., 2004 |
Prevalence of Barrett’s Esophagus
Barrett’s esophagus is histologically confirmed by specialized intestinal metaplasia in biopsies from a columnar-lined distal esophagus. Epidemiologic studies have consistently reported that the prevalence of Barrett’s esophagus-associated adenocarcinoma is very rare in Asia [65, 66]. Among 19,812 consecutive Chinese patients undergoing upper endoscopy for routine health examination between June 2003 and December 2006, Barrett’s esophagus (BE) was confirmed only in 0.06% [45]. In another large Korean retrospective analysis of 70,103 patients undergoing upper endoscopy, 1% had suspected CLE. Of these patients, BE was histologically confirmed in 0.22% [67]. In the earliest study on Barrett’s esophagus from Asia confirmed on histopathology, Yeh et al. reported a prevalence of 2% [65].
The prevalence of Barrett’s esophagus was reported between 0.3 and 2% [62, 68,69,70,71,72,73] in tertiary hospitals from various regions of Asia. Recent large studies from Korea and Taiwan have yielded prevalence rates of 0.01 and 0.03% for LSBE and 0.14 and 2.4% for SSBE, respectively [45, 67]. In India, Amarapukar et al. showed prevalence of 2.6% [74]. It has been commented previously that Japanese studies report a higher prevalence of Barrett’s owing to a different definition of the gastroesophageal junction [73].
Changing GERD Trends in Asia
The prevalence rates of both GERD symptoms and erosive esophagitis in a majority of recent reports have, in general, been higher than in earlier studies. This may be due to better diagnosis and recording of cases, but consistently higher rates from many centers in Asia are more likely to reflect a true increase in the prevalence of GERD.
A recent survey of 221 gastroenterologists, 205 primary care physicians, and 159 otolaryngologists across seven nations in Asia revealed that most (gastroenterologists, 90%; primary care physicians, 67%; otolaryngologists, 65%) perceive a rising occurrence of GERD [75]. Although there is a lack of longitudinal studies on the same source population to determine absolute change of GERD prevalence over time, recent reports from cross-sectional studies conducted across Asia indicate a general upward trend in the prevalence of GERD, [23, 43] with a rising proportion of patients presenting with reflux esophagitis [23, 43] and Barrett’s esophagus or metaplasia [43, 75].
In a longitudinal five-year follow-up study looking at reflux symptoms, Lim et al. from Singapore reported a rise in the prevalence of reflux symptoms from 1.6 to 9.9% [23]. In another study from a small town in Western Japan over a 6-year period, 15.4% of GERD cases were identified as new cases [76]. More studies on changes in prevalence of reflux esophagitis with time have been carried out. Ho et al. from Singapore tracked the prevalence of esophagitis in their endoscopy records over a nine-year period and recorded an increase from 3.9 to 9.8% [53]. A study of 23,870 upper gastrointestinal endoscopies in a single Japanese center provides support for the Singapore results, showing the prevalence of reflux esophagitis increased from 0.8% in 1975–1977 to 2.3% in 1995–1997 [77].
Cross-sectional studies in Asia have also shown rising prevalence of GERD. In Korea, a study around 2005–2007 showed a GERD prevalence of 8.2% based on weekly symptoms of heartburn and/or acid regurgitation; this compares with the mere 3.5% based on the same criteria reported in a 2000–2001 study [17, 43]. Similarly, a 2003 study from South China estimated the prevalence of GERD based on weekly symptoms of heartburn and/or acid regurgitation at 6.2%, [12] in contrast to the modest 3.1% based on weekly heartburn reported by a study conducted in Beijing and Shanghai approximately a decade ago [78].
Erosive esophagitis prevalence has also shown a similar trend. The prevalence of endoscopic reflux esophagitis in Eastern Asia was 3.4–5.0% [77, 78] before 2000, and 6.6–15.0% [41,42,43,44,45] from 2000 to 2005. Japan witnessed an almost fivefold increase in the prevalence of esophagitis (latest figures are 13.8% of patients who underwent their first upper gastrointestinal endoscopy and 16.3% of patients on routine physical examinations) since the 1970s [63, 82].
Rising prevalence is also evident in Korea where the most recent (2004–2005) study reported finding reflux esophagitis in 18.8% of all dyspeptic patients undergoing EGD; [79] this is more than fivefold that reported a decade ago (3.4% during the period 1996–1998) [77] and is the highest esophagitis rate reported in Southeast and East Asia thus far.
On the heels of this rising trend are Malaysia and Taiwan, where esophagitis was seen in 13.4% (patients who underwent endoscopy) [51] and 14.5% (patients with upper gastrointestinal symptoms) [62]. The study, conducted at a single center in Malaysia, saw an almost fivefold increase within the decade encompassing the 1990s and early 2000s. On a smaller scale, the Philippines witnessed a twofold increase in esophagitis prevalence (6.3% vs. 2.9%, based on endoscopic diagnoses) within a span of approximately 10 years from 1992 [80]. However, despite the remarkable upsurge in prevalence, the esophagitis cases seen in the region remain largely mild; more than 80% of the cases in the above-mentioned Japanese and Malaysian studies were grade A type according to Los Angeles classification.
Why is GERD Increasing in Asia?
Most Asian patients have nonerosive GERD; erosive esophagitis is less commonly seen than in the Western population. Asians are known to be less predisposed to GERD than Caucasians due to their inherent smaller gastric parietal cell mass and lower acid output, low body mass index, lower obesity, lower consumption of alcohol, and probably also their traditional low-fat diet [81]. A high prevalence of H. pylori in Asia is also accounted as a reason for low GERD predisposition [53]. There is evidence to suggest that changing dynamics in various risk and protective factors contribute to both an increased incidence and severity of GERD in Asia. Despite these theories, the exact reason for the increasing trend in GERD in Asia is difficult to determine. This has been proposed as a result of interaction of environmental and genetic factors. The increase in prevalence occurring over a relatively short period of time (10–20 years) points to the predominant role of environmental factors. The growing affluence and socioeconomic development in Asia has resulted in consequent lifestyle changes. A change in diet and physical activity and an increase in BMI and obesity have often been thought to be putative. Also, life expectancy has now increased markedly, and a higher prevalence of GERD could also reflect the aging of the population.
Summary
There is evidence to suggest that changing dynamics in various risk and protective factors contribute to both an increased incidence and severity of GERD in Asia. It is therefore of utmost importance for both primary care physicians and specialists to increase vigilance for this emerging disease. General public awareness is required to facilitate early intervention for risk factors, more accurate diagnoses, and appropriate treatment. The development and validation of diagnostic questionnaires that are universally applicable in Asian countries of different ethnic and cultural origins are challenging tasks, but it is necessary to facilitate research into the epidemiology of GERD in Asia. Further studies are required to elucidate the clinical course of GERD and the time trend of its complications, such as Barrett’s esophagus and adenocarcinoma of the esophagus. Differences may also be attributed to referral patterns, diagnostic practices, and physician recognition.
References
Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.
Kang JY, Tay HH, Yap I, Guan R, Lim KP, Math MV. Low frequency of endoscopic esophagitis in Asian patients. J Clin Gastroenterol. 1993;16:70–3.
Chen PC, Wu CS, Chang-Chien CS, Liaw YF. Comparison of Olympus GIF-P2 and GIF-K panendoscopy. Taiwan Yi Xue Hui Za Zhi. 1979;78:136–40. [Article in Chinese]
Wang TH, Lai MY, Lin RT, Wu CF, Chen DS, Wang CY, et al. Clinical experience with the upper gastrointestinal panendoscope GIF-P(2) (Olympus) (author’s transl). Taiwan Yi Xue Hui Za Zhi. 1978;77:44–55.
Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398–407.
Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care. 1993;11:252–62.
Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Watanabe T, Tominaga K, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–9.
Ohara S, Kawano T, Kusano M, Kouzu T. Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan. J Gastroenterol. 2011;46:603–11.
Yamagishi H, Koike T, Ohara S, Kobayashi S, Ariizumi K, Abe Y, et al. Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan. World J Gastroenterol. 2008;14:1358–64.
He J, Ma X, Zhao Y, Wang R, Yan X, Yan H, et al. A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the systematic investigation of gastrointestinal diseases in China. BMC Gastroenterol. 2010;10:94.
Li YM, Du J, Zhang H, Yu CH. Epidemiological investigation in outpatients with symptomatic gastroesophageal reflux from the Department of Medicine in Zhejiang Province, east China. J Gastroenterol Hepatol. 2008;23:283–9.
Chen M, Xiong L, Chen H, Xu A, He L, Hu P. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China. Scand J Gastroenterol. 2005;40:759–67.
Ma XQ, Cao Y, Wang R, Yan X, Zhao Y, Zou D, et al. Prevalence of, and factors associated with, gastroesophageal reflux disease: a population-based study in shanghai. China Dis Esophagus. 2009;22:317–22.
Wang R, Yan X, Ma XQ, Cao Y, Wallander MA, Johansson S, et al. Burden of gastroesophageal reflux disease in shanghai. China Dig Liver Dis. 2009;41:110–5.
Cheung TK, Lam KF, Hu WH, Lam CL, Wong WM, Hui WM, et al. Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese population. Aliment Pharmacol Ther. 2007;25:1099–104.
Wong WM, Lai KC, Lam KF, Hui WM, Hu WH, Lam CL, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther. 2003;18:595–604.
Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, Kim SW, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si. Korea Am J Gastroenterol. 2005;100:747–53.
Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 2009;79:196–201.
Lu CL, Lang HC, Chang FY, Chen TJ, Chen CY, Luo JC, et al. Social and medical impact, sleep quality and the pharmaceutical costs of heartburn in Taiwan. Aliment Pharmacol Ther. 2005;22:739–47.
Ronkainen J, Agreus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol. 2013;27:325–37.
Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the domestic/international gastroenterology surveillance study (DIGEST). Scand J Gastroenterol Suppl. 1999;231:29–37.
Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol. 1998;93:1816–22.
Lim SL, Goh WT, Lee JM, Ng TP, Ho KY; Community Medicine GI Study Group. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J Gastroenterol Hepatol 2005;20:995–1001.
Rajendra S, Alahuddin S. Racial differences in the prevalence of heartburn. Aliment Pharmacol Ther. 2004;19:375–6.
Nasseri-Moghaddam S, Mofid A, Ghotbi MH, Razjouyan H, Nouraie M, Ramard AR, et al. Epidemiological study of gastro-oesophageal reflux disease: reflux in spouse as a risk factor. Aliment Pharmacol Ther. 2008;28:144–53.
Solhpour A, Pourhoseingholi MA, Soltani F, Zarghi A, Habibi M, Ghafarnejad F, et al. Gastro-esophageal reflux symptoms and body mass index: no relation among the Iranian population. Indian J Gastroenterol. 2008;27:153–5.
Somi MH, Farhang S, Mirinezhad K, Jazayeri E, Nasseri-Moghaddam S, Moayeri S, et al. Prevalence and precipitating factors of gastroesophageal reflux disease in a young population of Tabriz. Northwest Iran Saudi Med J. 2006;27:1878–81.
Rokonuzzaman SM, Bhuian MR, Ali MH, Paul GK, Khan MR, Mamun AA. Epidemiological study of gastro-esophageal reflux disease in rural population. Mymensingh Med J. 2011;20:463–71.
Shaha M, Perveen I, Alamgir MJ, Masud MH, Rahman MH. Prevalence and risk factors for gastro-esophageal reflux disease in the north-eastern part of Bangladesh. Bangladesh Med Res Counc Bull. 2012;38:108–13.
Jafri N, Jafri W, Yakoob J, Islam M, Manzoor S, Jalil A, et al. Perception of gastroesophageal reflux disease in urban population in Pakistan. J Coll Physicians Surg Pak. 2005;15:532–4.
Bhatia SJ, Reddy DN, Ghoshal UC, Jayanthi V, Abraham P, Choudhuri G, et al. Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2011;30(3):118.
Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol. 2001;20:103–6.
Sharma PK, Ahuja V, Madan K, Gupta S, Raizada A, Sharma MP. Prevalence, severity, and risk factors of symptomatic gastroesophageal reflux disease among employees of a large hospital in northern India. Indian J Gastroenterol. 2011;30:128–34.
Kumar S, Sharma S, Norboo T, Dolma D, Norboo A, Stobdan T, et al. Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area. Indian J Gastroenterol. 2011;30:135–43.
Bor S, Mandiracioglu A, Kitapcioglu G, Caymaz-Bor C, Gilbert RJ. Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol. 2005;100:759–65.
Kitapçioğlu G, Mandiracioğlu A, Caymaz Bor C, Bor S. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community. Turk J Gastroenterol. 2007;18:14–9.
Mungan Z. Prevalence and demographic determinants of gastroesophageal reflux disease (GERD) in the Turkish general population: a population-based cross-sectional study. Turk J Gastroenterol. 2012;23:323–32.
Moshkowitz M, Horowitz N, Halpern Z, Santo E. Gastroesophageal reflux disease symptoms: prevalence, sociodemographics and treatment patterns in the adult Israeli population. World J Gastroenterol. 2011;17:1332–5.
Sperber AD, Halpern Z, Shvartzman P, , Friger M, Freud T, Neville A, et al. Prevalence of GERD symptoms in a representative Israeli adult population. J Clin Gastroenterol 2007;41:457–461.
Pan GXG, Ke M, et al. Epidemiological study of symptomatic gastro-esophageal reflux disease in China: Beijing and Shanghai. Chin J Dig Dis. 2000;1:2–8.
Fujimoto K, Iwakiri R, Okamoto K, Oda K, Tanaka A, Tsunada S, et al. Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women. J Gastroenterol. 2003;38(Suppl 15):3–6.
Fujiwara Y, Higuchi K, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Association between gastroesophageal flap valve, reflux esophagitis, Barrett’s epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients. J Gastroenterol. 2003;38:533–9.
Kang MS, Park DI, Oh SY, Yoo TW, Ryu SH, Park JH, et al. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol. 2007;22:1656–61.
Lee HL, Eun CS, Lee OY, Jeon YC, Sohn JH, Han DS, et al. Association between GERD-related erosive esophagitis and obesity. J Clin Gastroenterol. 2008;42:672–5.
Tseng PH, Lee YC, Chiu HM, Huang SP, Liao WC, Chen CC, et al. Prevalence and clinical characteristics of Barrett’s esophagus in a Chinese general population. J Clin Gastroenterol. 2008;42:1074–9.
Kaji M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T, et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol. 2010;25:1151–6.
Kim N, Lee SW, Cho SI, Park CG, Yang CH, Kim HS, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008;27:173–85.
Noh YW, Jung HK, Kim SE, Jung SA. Overlap of erosive and non-erosive reflux diseases with functional gastrointestinal disorders according to Rome III criteria. J Neurogastroenterol Motil. 2010;16:148–56.
Yamagishi H, Koike T, Ohara S, Abe Y, Iijima K, Imatani A, et al. Clinical characteristics of gastroesophageal reflux disease in Japan. Hepato-Gastroenterology. 2009;56:1032–4.
Zou D, He J, Ma X, Chen J, Gong Y, Man X, et al. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC). Scand J Gastroenterol. 2011;46:133–41.
Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. Eur J Gastroenterol Hepatol. 2004;16:495–501.
Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett’s esophagus: the long and short of it all. Dig Dis Sci. 2004;49:237–42.
Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol. 2005;100:1923–8.
Al-Humayed SM, Mohamed-Elbagir AK, Al-Wabel AA, Argobi YA. The changing pattern of upper gastro-intestinal lesions in southern Saudi Arabia: an endoscopic study. Saudi J Gastroenterol. 2010;16:35–7.
Koop H, Schepp W, Muller-Lissner S, Madisch A, Micklefield G, Messmann H, et al. Consensus conference of the DGVS on gastroesophageal reflux. Z Gastroenterol. 2005;43:163–4. [Article in German]
Shimizu Y, Dobashi K, Kobayashi S, Ohki I, Tokushima M, Kusano M, et al. High prevalence of gastroesophageal reflux disease with minimal mucosal change in asthmatic patients. Tohoku J Exp Med. 2006;209:329–36.
Chen MJ, Wu MS, Lin JT, Chang KY, Chiu HM, Liao WC, et al. Gastroesophageal reflux disease and sleep quality in a Chinese population. J Formos Med Assoc. 2009;108:53–60.
Fujiwara Y, Kohata Y, Kaji M, Nebiki H, Yamasaki T, Sasaki E, et al. Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole. Digestion. 2010;81:135–41.
Kusano M, Kouzu T, Kawano T, Ohara S. Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population. J Gastroenterol. 2008;43:833–41.
Wang GR, Zhang H, Wang ZG, Jiang GS, Guo CH. Relationship between dental erosion and respiratory symptoms in patients with gastro-oesophageal reflux disease. J Dent. 2010;38:892–8.
Mohd H, Qua CS, Wong CH, Azman W, Goh KL. Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population. J Gastroenterol Hepatol. 2009;24:288–93.
Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R. Erosive esophagitis and Barrett’s esophagus in Taiwan: a higher frequency than expected. Dig Dis Sci. 1997;42:702–6.
Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol. 1999;34:441–4.
Inamori M, Togawa J, Nagase H, Abe Y, Umezawa T, Nakajima A, et al. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J Gastroenterol Hepatol. 2003;18:172–6.
Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729–35.
Tu CH, Lee CT, Perng DS, Chang CC, Hsu CH, Lee YC. Esophageal adenocarcinoma arising from Barrett’s epithelium in Taiwan. J Formos Med Assoc. 2007;106:664–8.
Kim JH, Rhee PL, Lee JH, Lee H, Choi YS, Son HJ, et al. Prevalence and risk factors of Barrett’s esophagus in Korea. J Gastroenterol Hepatol. 2007;22:908–12.
Chen MJ, Lee YC, Chiu HM, Wu MS, Wang HP, Lin JT. Time trends of endoscopic and pathological diagnoses related to gastroesophageal reflux disease in a Chinese population: eight years single institution experience. Dis Esophagus. 2010;23:201–7.
Gadour MO, Ayoola EA. Barrett’s oesophagus and oesophageal cancer in Saudi Arabia. Trop Gastroenterol. 1999;20:111–5.
Lee IS, Choi SC, Shim KN, Jee SR, Huh KC, Lee JH, et al. Prevalence of Barrett’s esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study. Dig Dis Sci. 2010;55:1932–9.
Odemiş B, Ciçek B, Zengin NI, Arhan M, Kacar S, Cengiz C, et al. Barrett’s esophagus and endoscopically assessed esophagogastric junction integrity in 1000 consecutive Turkish patients undergoing endoscopy: a prospective study. Dis Esophagus. 2009;22:649–55.
Park JJ, Kim JW, Kim HJ, Chung MG, Park SM, Baik GH, et al. The prevalence of and risk factors for Barrett’s esophagus in a Korean population: a nationwide multicenter prospective study. J Clin Gastroenterol. 2009;43:907–14.
Xiong LS, Cui Y, Wang JP, Wang JH, Xue L, Hu PJ, et al. Prevalence and risk factors of Barrett’s esophagus in patients undergoing endoscopy for upper gastrointestinal symptoms. J Dig Dis. 2010;11:83–7.
Amarapurkar AD, Vora IM, Dhawan PS. Barrett’s esophagus. Indian J Pathol Microbiol. 1998;41:431–5.
Wong WM, Lim P, Wong BC. Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey. J Gastroenterol Hepatol. 2004;19(Suppl 3):S54–60.
Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study. J Gastroenterol Hepatol. 2008;23:393–7.
Lee SJ, Song CW, Jeen YT, Chun HJ, Lee HS, Um SH, et al. Prevalence of endoscopic reflux esophagitis among Koreans. J Gastroenterol Hepatol. 2001;16:373–6.
Lien HC, Chang CS, Yeh HZ, , Ko CW, Chang HY, Cheng KF, et al. Increasing prevalence of erosive esophagitis among Taiwanese aged 40 years and above: a comparison between two time periods. J Clin Gastroenterol 2009;43:926–932.
Song HJ, Choi KD, Jung HY, Lee GH, Jo JY, Byeon JS, et al. Endoscopic reflux esophagitis in patients with upper abdominal pain-predominant dyspepsia. J Gastroenterol Hepatol. 2007;22:2217–21.
Sollano JD, Wong SN, Andal-Gamutan T, Chan MM, Carpio RE, Tady CS, et al. Erosive esophagitis in the Philippines: a comparison between two time periods. J Gastroenterol Hepatol. 2007;22:1650–5.
Ho KY, Cheung TK, Wong BC. Gastroesophageal reflux disease in Asian countries: disorder of nature or nurture? J Gastroenterol Hepatol. 2006;21:1362–5.
Cheung TK, Wong BC, Lam SK. Gastro-oesophageal reflux disease in Asia: birth of a ‘new’ disease? Drugs. 2008;68:399–406.
Netinatsunton N, Attasaranya S, Ovartlarnporn B, , Sangnil S, Boonviriya S, Piratvisuth T. The value of Carlsson-dent questionnaire in diagnosis of gastroesophageal reflux disease in area with low prevalence of gastroesophageal reflux disease. J Neurogastroenterol Motil. 2011;17:164–168.
Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil. 2011;17:14–27.
Wai CT, Yeoh KG, Ho KY, Kang JY, Lim SG. Diagnostic yield of upper endoscopy in Asian patients presenting with dyspepsia. Gastrointest Endosc. 2002;56:548–51.
Yilmaz N, Tuncer K, Tuncyurek M, Ozütemiz O, Bor S. The prevalence of Barrett’s esophagus and erosive esophagitis in a tertiary referral center in Turkey. Turk J Gastroenterol. 2006;17:79–83.
Amano Y, Ishimura N, Furuta K, , Takahashi Y, Chinuki D, Mishima Y, et al. Which landmark results in a more consistent diagnosis of Barrett’s esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc 2006;64:206–211.
Manabe N, Mihara HK, et al. The increasing incidence of reflux esophagitis during the past 20 years in Japan. Gastroenterology. 1999;116:A224.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer India
About this chapter
Cite this chapter
Bhatia, S., Gupta, D.K., Vennalaganti, P. (2018). Epidemiology of Gastroesophageal Reflux in Asia. In: Sharma, P., Bhatia, S., Goh, K. (eds) The Rise of Acid Reflux in Asia. Springer, New Delhi. https://doi.org/10.1007/978-81-322-0846-4_2
Download citation
DOI: https://doi.org/10.1007/978-81-322-0846-4_2
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-0845-7
Online ISBN: 978-81-322-0846-4
eBook Packages: MedicineMedicine (R0)